Measuring change in trials of physical activity interventions: a comparison of self-report questionnaire and accelerometry within the PACE-UP trial.
Study Goal
The researchers aimed to compare changes in physical activity levels using self-reported (IPAQ) and objective (accelerometry) measures in response to pedometer-based walking interventions.
Results Summary
Both intervention groups significantly increased accelerometer-measured moderate-to-vigorous physical activity (MVPA) compared to control, while self-reported walking (IPAQ-Walk) also increased but with less precision. Self-reported MVPA (IPAQ-MVPA) showed non-significant decreases.
Population
1023 participants in the PACE-UP trial, with 655 providing complete data at baseline and 12 months.
Effective Dosage
Not specified (pedometer-based walking interventions).
Duration
12 months.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
pedometer-based walking intervention by post | increase | accelerometry moderate-to-vigorous PA (Acc-MVPA) minutes/week | participants in the PACE-UP trial | 42 (95% CI 22, 61) | significantly increased | #1 |
pedometer-based walking intervention with nurse support | increase | accelerometry moderate-to-vigorous PA (Acc-MVPA) minutes/week | participants in the PACE-UP trial | 43 (95% CI 24, 63) | significantly increased | #2 |
pedometer-based walking intervention by post | increase | IPAQ walking (IPAQ-Walk) minutes/week | participants in the PACE-UP trial | 57 (95% CI 2, 112) | increased | #3 |
pedometer-based walking intervention with nurse support | increase | IPAQ walking (IPAQ-Walk) minutes/week | participants in the PACE-UP trial | 43 (95% CI -11, 97) | increased | #4 |
pedometer-based walking intervention by post | decrease | IPAQ moderate+vigorous PA (IPAQ-MVPA) minutes/week | participants in the PACE-UP trial | -11 (95% CI -65, 42) | showed non-significant decreases | #5 |
pedometer-based walking intervention with nurse support | decrease | IPAQ moderate+vigorous PA (IPAQ-MVPA) minutes/week | participants in the PACE-UP trial | -34 (95% CI -87, 19) | showed non-significant decreases | #6 |
BACKGROUND: Few trials have compared estimates of change in physical activity (PA) levels using self-reported and objective PA measures when evaluating trial outcomes. The PACE-UP trial offered the opportunity to assess this, using the self-administered International Physical Activity Questionnaire (IPAQ) and waist-worn accelerometry. METHODS: The PACE-UP trial (N = 1023) compared usual care (n = 338) with two pedometer-based walking interventions, by post (n = 339) or with nurse support (n = 346). Participants wore an accelerometer at baseline and 12 months and completed IPAQ for the same 7-day periods. Main outcomes were weekly minutes, all in ≥10 min bouts as per UK PA guidelines of: i) accelerometer moderate-to-vigorous PA (Acc-MVPA) ii) IPAQ moderate+vigorous PA (IPAQ-MVPA) and iii) IPAQ walking (IPAQ-Walk). For each outcome, 12 month values were regressed on baseline to estimate change. RESULTS: Analyses were restricted to 655 (64%) participants who provided data on all outcomes at baseline and 12 months. Both intervention groups significantly increased their accelerometry MVPA minutes/week compared with control: postal group 42 (95% CI 22, 61), nurse group 43 (95% CI 24, 63). IPAQ-Walk minutes/week also increased: postal 57 (95% CI 2, 112), nurse 43 (95% CI -11, 97) but IPAQ-MVPA minutes/week showed non-significant decreases: postal -11 (95% CI -65, 42), nurse -34 (95% CI -87, 19). CONCLUSIONS: Our results demonstrate the necessity of using a questionnaire focussing on the activities being altered, as with IPAQ-Walk questions. Even then, the change in PA was estimated with far less precision than with accelerometry. Accelerometry is preferred to self-report measurement, minimising bias and improving precision when assessing effects of a walking intervention. TRIAL REGISTRATION: ISRCTN, ISRCTN98538934 . Registered 2 March 2012.